153 related articles for article (PubMed ID: 1655692)
1. Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium.
Endoh M; Satoh H; Norota I; Hirano K; Hosokawa T
Heart Vessels; 1991; 6(3):158-67. PubMed ID: 1655692
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.
Satoh H; Endoh M
Jpn J Pharmacol; 1990 Feb; 52(2):215-24. PubMed ID: 2156096
[TBL] [Abstract][Full Text] [Related]
3. Effects of a novel cardiotonic agent (+-)-6-[3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy]-2(1H)-quinolino ne (OPC-18790) on contractile force, cyclic AMP level, and aequorin light transients in dog ventricular myocardium.
Endoh M; Kawabata Y; Katano Y; Norota I
J Cardiovasc Pharmacol; 1994 May; 23(5):723-30. PubMed ID: 7521454
[TBL] [Abstract][Full Text] [Related]
4. Positive inotropic and negative chronotropic effects of OPC-8490, a newly developed cardiotonic, in isolated, blood-perfused canine heart preparations.
Furukawa Y; Akahane K; Haniuda M; Chiba S
Jpn Heart J; 1989 May; 30(3):387-98. PubMed ID: 2552190
[TBL] [Abstract][Full Text] [Related]
5. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
Katano Y; Endoh M
J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
[TBL] [Abstract][Full Text] [Related]
6. Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle.
Yanagisawa T; Endoh M; Taira N
Jpn J Pharmacol; 1984 Nov; 36(3):379-88. PubMed ID: 6097725
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle.
Endoh M; Satoh H; Norota I; Hirano K
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1127-34. PubMed ID: 1964579
[TBL] [Abstract][Full Text] [Related]
8. Positive inotropic effect of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1 -piperazinyl]-2(1H)-quinolinone (OPC-8212) and mechanism of action in guinea pig ventricular myocardium.
Takeya K; Yajima M; Kobayashi-Ando S; Ando H
Arzneimittelforschung; 1984; 34(3A):364-70. PubMed ID: 6331466
[TBL] [Abstract][Full Text] [Related]
9. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.
Endoh M; Shibasaki T; Satoh H; Norota I; Ishihata A
J Cardiovasc Pharmacol; 1991 Mar; 17(3):365-75. PubMed ID: 1711596
[TBL] [Abstract][Full Text] [Related]
10. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N; Blinks JR
Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of OPC-8490 in human ventricular myocardium.
Focaccio A; Peeters G; Movsesian M; Roden R; Eki Y; Krall J; Bristow MR
Circulation; 1996 Feb; 93(4):817-25. PubMed ID: 8641012
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action.
Hosokawa T; Mori T; Fujiki H; Kinoshita S; Takemoto K; Imaizumi T; Noda T; Ohura M; Tominaga M; Yabuuchi Y
Heart Vessels; 1992; 7(2):66-75. PubMed ID: 1328145
[TBL] [Abstract][Full Text] [Related]
13. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
Endoh M; Yamashita S; Taira N
J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
[TBL] [Abstract][Full Text] [Related]
14. Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism.
Endoh M
Basic Res Cardiol; 1989; 84 Suppl 1():69-83. PubMed ID: 2554874
[TBL] [Abstract][Full Text] [Related]
15. Effects of a novel cardiotonic agent, Org 9731, on force and aequorin light transients in intact ventricular myocardium of the dog: involvement of a cyclic AMP-mediated mechanism and myofibrillar responsiveness to Ca2+ ions.
Kawabata Y; Endoh M
J Card Fail; 1995 Mar; 1(2):143-53. PubMed ID: 9420644
[TBL] [Abstract][Full Text] [Related]
16. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
Taira N; Endoh M; Iijima T; Satoh K; Yanagisawa T; Yamashita S; Maruyama M; Kawada M; Morita T; Wada Y
Arzneimittelforschung; 1984; 34(3A):347-55. PubMed ID: 6331465
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.
Endoh M; Yanagisawa T; Morita T; Taira N
J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of effects of UK-1745, a novel cardiotonic agent with beta-adrenoceptor-blocking action, in aequorin-loaded canine right ventricular muscle.
Sawada H; Endoh M
J Mol Cell Cardiol; 1999 May; 31(5):1047-62. PubMed ID: 10336843
[TBL] [Abstract][Full Text] [Related]
19. New positive inotropic agent OPC-8212 modulates single Ca2+ channels in ventricular myocytes of guinea pig.
Yatani A; Imoto Y; Schwartz A; Brown AM
J Cardiovasc Pharmacol; 1989 Jun; 13(6):812-9. PubMed ID: 2484074
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
